Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02340143 · ClinicalTrials.gov registry record · NA
Assessing Early Behavioral Indicators of Formula Tolerance
A NA study, sponsored by Mead Johnson Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT02340143: Completed NA study, sponsored by Mead Johnson Nutrition.
NCT02340143 is a NA study that has completed, run by Mead Johnson Nutrition. The registered enrollment target is 71 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02340143, a NA study, has completed, sponsored by Mead Johnson Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
The study is intended to assess the amount of crying and fussiness in infants fed an infant formula containing probiotics.
Interventions
- OTHER Control
- OTHER Investigational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT02340143 record still lists
NCT02340143 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT02340143 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02340143 about?
NCT02340143 is a clinical study titled "Assessing Early Behavioral Indicators of Formula Tolerance". The study is intended to assess the amount of crying and fussiness in infants fed an infant formula containing probiotics.
What is the current status of trial NCT02340143?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2015-01. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02340143?
The interventions under investigation include: Control (OTHER), Investigational (OTHER).
Who is sponsoring clinical trial NCT02340143?
This trial is sponsored by Mead Johnson Nutrition, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02340143's enrollment target sits among peer trials
71 1102nd of 2000 higher than 898 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia